Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

NCT00408538 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: UC-781 microbicide gel (0.1% and 0.25%)
DRUG: placebo

Sponsor

University of California, Los Angeles

Collaborators

[object Object]
[object Object]